Author: AICPA
Publisher: John Wiley & Sons
ISBN: 1937352781
Category : Business & Economics
Languages : en
Pages : 208
Book Description
This new guide provides guidance and illustrations regarding the initial and subsequent accounting for, valuation of, and disclosures related to acquired intangible assets used in research and development activities (IPR&D assets). This is a valuable resource for preparers of financial statements, auditors, accountants and valuation specialists seeking an advanced understanding of the accounting, valuation, and disclosures related to acquired IPR&D assets.
Accounting and Valuation Guide: Assets Acquired to Be Used in Research and Development Activities
Author: AICPA
Publisher: John Wiley & Sons
ISBN: 1937352781
Category : Business & Economics
Languages : en
Pages : 208
Book Description
This new guide provides guidance and illustrations regarding the initial and subsequent accounting for, valuation of, and disclosures related to acquired intangible assets used in research and development activities (IPR&D assets). This is a valuable resource for preparers of financial statements, auditors, accountants and valuation specialists seeking an advanced understanding of the accounting, valuation, and disclosures related to acquired IPR&D assets.
Publisher: John Wiley & Sons
ISBN: 1937352781
Category : Business & Economics
Languages : en
Pages : 208
Book Description
This new guide provides guidance and illustrations regarding the initial and subsequent accounting for, valuation of, and disclosures related to acquired intangible assets used in research and development activities (IPR&D assets). This is a valuable resource for preparers of financial statements, auditors, accountants and valuation specialists seeking an advanced understanding of the accounting, valuation, and disclosures related to acquired IPR&D assets.
FRS 102
Author:
Publisher:
ISBN: 9780754553625
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN: 9780754553625
Category :
Languages : en
Pages :
Book Description
The Measurement of Scientific, Technological and Innovation Activities Frascati Manual 2015 Guidelines for Collecting and Reporting Data on Research and Experimental Development
Author: OECD
Publisher: OECD Publishing
ISBN: 9264239014
Category :
Languages : en
Pages : 402
Book Description
The internationally recognised methodology for collecting and using R&D statistics, the OECD's Frascati Manual is an essential tool for statisticians and science and innovation policy makers worldwide. It includes definitions of basic concepts, data collection guidelines, and classifications ...
Publisher: OECD Publishing
ISBN: 9264239014
Category :
Languages : en
Pages : 402
Book Description
The internationally recognised methodology for collecting and using R&D statistics, the OECD's Frascati Manual is an essential tool for statisticians and science and innovation policy makers worldwide. It includes definitions of basic concepts, data collection guidelines, and classifications ...
Estimates of Federal Tax Expenditures
Author: United States. Congress. Joint Committee on Internal Revenue Taxation
Publisher:
ISBN:
Category : Revenue
Languages : en
Pages : 20
Book Description
Publisher:
ISBN:
Category : Revenue
Languages : en
Pages : 20
Book Description
Basis of Assets
Author:
Publisher:
ISBN:
Category : Capital gains tax
Languages : en
Pages : 20
Book Description
Publisher:
ISBN:
Category : Capital gains tax
Languages : en
Pages : 20
Book Description
Research and Development Expenditures
Author: Kendall B. Fox
Publisher:
ISBN: 9781633593251
Category : Research and development tax credit
Languages : en
Pages :
Book Description
Because of the interaction between the research and development (R&D) expensing provisions and the tax credit, this Portfolio discusses these two issues in parallel. It first considers what types of activities give rise to expenditures that qualify as research and experimental expenditures for current expensing purposes, and then considers what types of activities can give rise to expenditures eligible for the research deduction or tax credit. The Portfolio also discusses several practical and technical issues in claiming the research credit, the basic research tax credit, and various miscellaneous matters. Because of the interaction between the research and development (R&D) expensing provisions and the tax credit, this Portfolio discusses these two issues in parallel. It first considers what types of activities give rise to expenditures that qualify as research and experimental expenditures for current expensing purposes, and then considers what types of activities can give rise to expenditures eligible for the research deduction or tax credit. The Portfolio also discusses several practical and technical issues in claiming the research credit, the basic research tax credit, and various miscellaneous matters. Because of the interaction between the research and development (R&D) expensing provisions and the tax credit, this Portfolio discusses these two issues in parallel. It first considers what types of activities give rise to expenditures that qualify as research and experimental expenditures for current expensing purposes, and then considers what types of activities can give rise to expenditures eligible for the research deduction or tax credit. The Portfolio also discusses several practical and technical issues in claiming the research credit, the basic research tax credit, and various miscellaneous matters.
Publisher:
ISBN: 9781633593251
Category : Research and development tax credit
Languages : en
Pages :
Book Description
Because of the interaction between the research and development (R&D) expensing provisions and the tax credit, this Portfolio discusses these two issues in parallel. It first considers what types of activities give rise to expenditures that qualify as research and experimental expenditures for current expensing purposes, and then considers what types of activities can give rise to expenditures eligible for the research deduction or tax credit. The Portfolio also discusses several practical and technical issues in claiming the research credit, the basic research tax credit, and various miscellaneous matters. Because of the interaction between the research and development (R&D) expensing provisions and the tax credit, this Portfolio discusses these two issues in parallel. It first considers what types of activities give rise to expenditures that qualify as research and experimental expenditures for current expensing purposes, and then considers what types of activities can give rise to expenditures eligible for the research deduction or tax credit. The Portfolio also discusses several practical and technical issues in claiming the research credit, the basic research tax credit, and various miscellaneous matters. Because of the interaction between the research and development (R&D) expensing provisions and the tax credit, this Portfolio discusses these two issues in parallel. It first considers what types of activities give rise to expenditures that qualify as research and experimental expenditures for current expensing purposes, and then considers what types of activities can give rise to expenditures eligible for the research deduction or tax credit. The Portfolio also discusses several practical and technical issues in claiming the research credit, the basic research tax credit, and various miscellaneous matters.
Research and Development in the Pharmaceutical Industry (A CBO Study)
Author: Congressional Budget Office
Publisher: Lulu.com
ISBN: 1304121445
Category : Science
Languages : en
Pages : 65
Book Description
Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...
Publisher: Lulu.com
ISBN: 1304121445
Category : Science
Languages : en
Pages : 65
Book Description
Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...
Farmer's Tax Guide
Author:
Publisher:
ISBN:
Category : Agriculture
Languages : en
Pages : 112
Book Description
Publisher:
ISBN:
Category : Agriculture
Languages : en
Pages : 112
Book Description
Self-employment Tax
Author:
Publisher:
ISBN:
Category : Income tax
Languages : en
Pages : 12
Book Description
Publisher:
ISBN:
Category : Income tax
Languages : en
Pages : 12
Book Description
International Taxation of Banking
Author: John Abrahamson
Publisher: Kluwer Law International B.V.
ISBN: 9403510951
Category : Law
Languages : en
Pages : 468
Book Description
Banking is an increasingly global business, with a complex network of international transactions within multinational groups and with international customers. This book provides a thorough, practical analysis of international taxation issues as they affect the banking industry. Thoroughly explaining banking’s significant benefits and risks and its taxable activities, the book’s broad scope examines such issues as the following: taxation of dividends and branch profits derived from other countries; transfer pricing and branch profit attribution; taxation of global trading activities; tax risk management; provision of services and intangible property within multinational groups; taxation treatment of research and development expenses; availability of tax incentives such as patent box tax regimes; swaps and other derivatives; loan provisions and debt restructuring; financial technology (FinTech); group treasury, interest flows, and thin capitalisation; tax havens and controlled foreign companies; and taxation policy developments and trends. Case studies show how international tax analysis can be applied to specific examples. The Organisation for Economic Co-operation and Development Base Erosion and Profit Shifting (OECD BEPS) measures and how they apply to banking taxation are discussed. The related provisions of the OECD Model Tax Convention are analysed in detail. The banking industry is characterised by rapid change, including increased diversification with new banking products and services, and the increasing significance of activities such as shadow banking outside current regulatory regimes. For all these reasons and more, this book will prove to be an invaluable springboard for problem solving and mastering international taxation issues arising from banking. The book will be welcomed by corporate counsel, banking law practitioners, and all professionals, officials, and academics concerned with finance and its tax ramifications.
Publisher: Kluwer Law International B.V.
ISBN: 9403510951
Category : Law
Languages : en
Pages : 468
Book Description
Banking is an increasingly global business, with a complex network of international transactions within multinational groups and with international customers. This book provides a thorough, practical analysis of international taxation issues as they affect the banking industry. Thoroughly explaining banking’s significant benefits and risks and its taxable activities, the book’s broad scope examines such issues as the following: taxation of dividends and branch profits derived from other countries; transfer pricing and branch profit attribution; taxation of global trading activities; tax risk management; provision of services and intangible property within multinational groups; taxation treatment of research and development expenses; availability of tax incentives such as patent box tax regimes; swaps and other derivatives; loan provisions and debt restructuring; financial technology (FinTech); group treasury, interest flows, and thin capitalisation; tax havens and controlled foreign companies; and taxation policy developments and trends. Case studies show how international tax analysis can be applied to specific examples. The Organisation for Economic Co-operation and Development Base Erosion and Profit Shifting (OECD BEPS) measures and how they apply to banking taxation are discussed. The related provisions of the OECD Model Tax Convention are analysed in detail. The banking industry is characterised by rapid change, including increased diversification with new banking products and services, and the increasing significance of activities such as shadow banking outside current regulatory regimes. For all these reasons and more, this book will prove to be an invaluable springboard for problem solving and mastering international taxation issues arising from banking. The book will be welcomed by corporate counsel, banking law practitioners, and all professionals, officials, and academics concerned with finance and its tax ramifications.